| 纯度 | > 90 % SDS-PAGE. |
| 种属 | Human |
| 靶点 | CA13 |
| Uniprot No | Q8N1Q1 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-262aa |
| 氨基酸序列 | MSRLSWG YREHNGPIHW KEFFPIADGD QQSPIEIKTK EVKYDSSLRP LSIKYDPSSA KIISNSGHSF NVDFDDTENK SVLRGGPLTG SYRLRQVHLH WGSADDHGSE HIVDGVSYAA ELHVVHWNSD KYPSFVEAAH EPDGLAVLGV FLQIGEPNSQ LQKITDTLDS IKEKGKQTRF TNFDLLSLLP PSWDYWTYPG SLTVPPLLES VTWIVLKQPI NISSQQLAKF RSLLCTAEGE AAAFLVSNHR PPQPLKGRKV RASFH |
| 预测分子量 | 32 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于CA13重组蛋白的3篇示例参考文献(注：文献信息为模拟示例，仅供参考格式)：
1. **文献名称**：*Cloning and Expression of Recombinant Human Carbonic Anhydrase XIII in E. coli*
**作者**：Smith A, et al.
**摘要**：该研究成功在大肠杆菌中克隆并表达了重组人CA13蛋白，优化了纯化条件，并通过质谱和酶活性测定验证了其生物活性，为后续功能研究提供了基础。
2. **文献名称**：*Structural Insights into CA XIII: Crystallographic Analysis of a Novel Isoform*
**作者**：Johnson R, et al.
**摘要**：通过X射线晶体学解析了CA13的三维结构，揭示了其活性位点的独特氨基酸组成，并探讨了与其他碳酸酐酶亚型的功能差异。
3. **文献名称**：*Role of CA XIII in Respiratory Physiology: A Knockout Mouse Study*
**作者**：Lee S, et al.
**摘要**：利用CA13基因敲除小鼠模型，发现CA13在肺组织二氧化碳代谢中发挥辅助作用，并可能与慢性呼吸疾病相关。
---
如需真实文献，建议通过PubMed或SciFinder检索关键词“CA13 recombinant protein”或“carbonic anhydrase XIII expression”获取最新研究。
CA13 (Carbonic Anhydrase XIII) is a member of the carbonic anhydrase (CA) family, a group of zinc metalloenzymes that catalyze the reversible hydration of carbon dioxide (CO₂) to bicarbonate (HCO₃⁻) and protons (H⁺). This reaction is critical for maintaining acid-base balance, ion transport, and metabolic processes in various tissues. Among the 15 human CA isoforms, CA13 is a relatively less studied enzyme encoded by the *CA13* gene. It is classified as a secreted protein due to its extracellular localization, though its precise physiological role remains under investigation.
CA13 is expressed in specific tissues, including salivary glands, respiratory epithelium, and the kidney, suggesting potential roles in modulating bicarbonate-rich secretions or regulating local pH environments. Unlike other CA isoforms (e.g., CA II or CA IX), CA13 exhibits distinct structural features, such as a unique N-terminal signal peptide for secretion and variations in active-site residues, which may influence its catalytic efficiency or substrate specificity.
Recombinant CA13 protein is produced using heterologous expression systems (e.g., *E. coli* or mammalian cells*) to enable functional and structural studies. Its recombinant form allows researchers to explore its enzymatic kinetics, inhibitor interactions, and potential biomedical applications. For instance, CA13 has been implicated in diseases like cancers and metabolic disorders, where aberrant CA activity may contribute to pathogenesis. Additionally, CA13 inhibitors could serve as therapeutic agents or diagnostic tools, though further validation is required.
The development of recombinant CA13 also aids in elucidating its role in physiological processes, such as mucosal defense or fluid homeostasis, and provides a platform for comparative studies with other CA isoforms. Despite its lower catalytic activity compared to dominant isoforms like CA II, CA13’s unique tissue distribution and secretory nature highlight its specialized biological significance, warranting deeper exploration into its molecular mechanisms and therapeutic potential.
×
